Search research articles
Contact Us
Filters
Showing results (161-170 of 179) with videos related to
Page
of 18
Sort By:
Pediatric Blood & Cancer
|
November 19, 2024
Centralized Investigator Review of Radiological and Functional Imaging Reports in Real-World Oncology Studies: The SACHA-France Experience
Pablo Berlanga, Isabelle Aerts, Nadège Corradini, et al.
The Lancet. Oncology
|
February 28, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S Hong, Steven G DuBois, Shivaani Kummar, et al.
Molecular Cancer
|
August 18, 2023
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Antonino Glaviano, Aaron S C Foo, Hiu Y Lam, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 16, 2026
Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Lisa Mayr, Leah Mager, Lisa Gabler-Pamer, et al.
Science Translational Medicine
|
June 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
Cristina Mastini, Marco Campisi, Enrico Patrucco, et al.
Neuro-Oncology
|
December 1, 2021
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
François Doz, Cornelis M van Tilburg, Birgit Geoerger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
Alba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
Communications Biology
|
September 18, 2023
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors
Maria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec, et al.
Nature Communications
|
August 21, 2025
Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition
Femke C A S Ringnalda, Gijs J F van Son, Laurens H G Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC study
Fernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 179) with videos related to
Sort By:
Page
of 18
Pediatric Blood & Cancer
|
November 19, 2024
Centralized Investigator Review of Radiological and Functional Imaging Reports in Real-World Oncology Studies: The SACHA-France Experience
Pablo Berlanga, Isabelle Aerts, Nadège Corradini, et al.
The Lancet. Oncology
|
February 28, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S Hong, Steven G DuBois, Shivaani Kummar, et al.
Molecular Cancer
|
August 18, 2023
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Antonino Glaviano, Aaron S C Foo, Hiu Y Lam, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 16, 2026
Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Lisa Mayr, Leah Mager, Lisa Gabler-Pamer, et al.
Science Translational Medicine
|
June 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
Cristina Mastini, Marco Campisi, Enrico Patrucco, et al.
Neuro-Oncology
|
December 1, 2021
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
François Doz, Cornelis M van Tilburg, Birgit Geoerger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
Alba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
Communications Biology
|
September 18, 2023
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors
Maria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec, et al.
Nature Communications
|
August 21, 2025
Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition
Femke C A S Ringnalda, Gijs J F van Son, Laurens H G Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC study
Fernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
Page
of 18